Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology

Transfusion

Volumn 45, Issue 6, 2005, Pages 920-926

  Li, Junzhi ^b   Lockerbie, Owen ^b   De Korte, Dirk ^b   Rice, Joe ^b   McLean, Robyn ^b   Goodrich, Raymond P ^a  

^a Navigant Biotechnologies Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATE; GLUCOSE; MITOCHONDRIAL ENZYME; RIBOFLAVIN;

ACIDIFICATION; ACIDITY; AEROBIC METABOLISM; ARTICLE; AUTOMATION; BLOOD COMPONENT; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DEVICE; DISEASE TRANSMISSION; ENZYME ACTIVITY; EVALUATION AND FOLLOW UP; FLOW CYTOMETRY; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; HUMAN CELL; MEDICAL TECHNOLOGY; MITOCHONDRIAL MEMBRANE; PATHOGEN REDUCTION TECHNOLOGY; PRIMARY PREVENTION; QUANTITATIVE GENETICS; THROMBOCYTE; THROMBOCYTE PRESERVATION; ULTRAVIOLET IRRADIATION;

ADENOSINE TRIPHOSPHATE; BLOOD PLATELETS; BLOOD PRESERVATION; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; MITOCHONDRIA; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; RIBOFLAVIN; TEMPERATURE; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 20444419723     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04381.x     Document Type: Article

References (32)

1. Li J, Kuter DJ. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol 2001;74:365-74.
2. Murphy S. Platelet storage for transfusion. Semin Hematol 1985;22:165-77.
3. Murphy S. Metabolic patterns of platelets - impact on storage for transfusion. Vox Sang 1994;67(Suppl 3):271-3.
4. Akkerman JW. Regulation of carbohydrate metabolism in platelets: a review. Thromb Haemost 1978;39:712-24.
5. Soslau G. Cytochrome levels and activity in stored human platelets. Arch Biochem Biophys 1982;215:532-8.
6. Akkerman JW, Holmsen H, Loughnane M. Simultaneous measurement of aggregation, secretion, oxygen uptake, proton production, and intracellular metabolites in the same platelet suspension. Anal Biochem 1979;97:387-93.
7. 2+ secretion. Blood 1981;57:956-66.
8. Chaudhry AA, Sagone AL Jr, Metz EN, et al. Relationship of glucose oxidation to aggregation of human platelets. Blood 1973;41:249-58.
9. Doery JC, Hirsh J, Cooper I. Energy metabolism in human platelets: interrelationship between glycolysis and oxidative metabolism. Blood 1970;36:159-68.
10. Detwiler TC, Zivkovic RV. Control of energy metabolism in platelets: a comparison of aerobic and anaerobic metabolism in washed rat platelets. Biochim Biophys Acta 1970;197:117-26.
11. Detwiler TC. Control of energy metabolism in platelets: the effects of thrombin and cyanide on glycolysis. Biochim Biophys Acta 1972;256:163-74.
12. Akkerman JW, Rijksen G, Gorter G, et al. Platelet functions and energy metabolism in a patient with hexokinase deficiency. Blood 1984;63:147-53.
13. Kilkson H, Holme S, Murphy S. Platelet metabolism during storage of platelet concentrates at 22°C. Blood 1984;64:406-14.
14. Akkerman JW, Gorter G, Sixma JJ. Regulation of glycolytic flux in human platelets: relation between energy production by glyco(geno)lysis and energy consumption. Biochim Biophys Acta 1978;541:241-50.
15. Akkerman JW, Gorter G. Relation between energy production and adenine nucleotide metabolism in human blood platelets. Biochim Biophys Acta 1980;590:107-16.
16. Nishimura J, Minakami S. Effect of hydrogen ion concentration on energy metabolism in pig platelets. Biochim Biophys Acta 1975;396:1-10.
17. Rossi EC. Effects of ethylenediaminetetraacetate (EDTA) and citrate upon platelet glycolysis. J Lab Clin Med 1967;69:204-16.
18. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 2000;78(Suppl 2):211-5.
19. Kumar V, Lockerbie O, Keil SD, et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004;80:15-21.
20. Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004;44:877-85.
21. Escolar G, Lozano M, Diaz-Ricart M, et al. Effects of a new pathogen reduction technology (Mirasol PRT) on platelet function. Vox Sang 2004;87:68.
22. AuBuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2004;44:16A.
23. Arnold DM, Heddle NM, Carruthers J, et al. A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets. Transfusion 2004;44:1A.
24. AuBuchon JP, Herschel L, Roger I, et al. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion 2004;44:36-41.
25. Corash L, Behrman B, Rheinschmidt M, et al. Post-transfusion viability and tolerability of photochemically treated platelet. Blood 1997;90:267a.
26. Dumont LJ, AuBuchon JP, Whitley P, et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002;42:847-54.
27. Murphy S. Radiolabeling of PLTs to assess viability: a proposal for a standard. Transfusion 2004;44:131-3.
28. Li J, De Korte D, Woolum MD, et al. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products. Vox Sang 2004;87:82-90.
29. Li J, Xia Y, Bertino AM, et al. The mechanism of apoptosis in human platelets during storage. Transfusion 2000;40:1320-9.
30. Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003;43:526-35.
31. Verhoeven AJ, Verhaar R, Gouwerok EG, de Korte D. The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion 2005;45:82-9.
32. Xia Y, Li J, Bertino A, et al. Thrombopoietin and the TPO receptorduring platelet storage. Transfusion 2000;40:976-87.